|
Edoxaban Might Be Effective for Atrial Fibrillation Patients After TAVR
|
|
Patients who have undergone transcatheter aortic valve replacement (TAVR) are often prescribed warfarin. A new study finds, however, that edoxaban, which involves fewer restrictions than warfarin, might be a good alternative for those patients who often have a diagnosis of atrial fibrillation. Here are more details.
|
|
|
COVID-19 Vaccine Offers Reduced Protection for Immunocompromised Patients
|
|
|
While immunosuppressed patients get some protection from taking mRNA COVID-19 vaccines, it tends to be only a third as strong as that produced in healthy people, according to a new study. That’s why a third “booster” shot is so important to boost antibodies in those patients with chronic inflammatory disease. Here is more information.
|
|
Several Health Systems Refuse to Cover Controversial New Alzheimer’s Drug
|
|
|
FDA approval of the Alzheimer’s drug aducanumab, marketed as Aduhelm, was controversial, and several large healthcare systems—including the Veterans Health Administration—are refusing to offer full coverage of it. Find out why those health systems came to that conclusion and what concerns are being expressed about the drug.
|
|
|
Here’s Why Recovered COVID-19 Patients Still Need Two Shots
of Vaccine
|
|
Pharmacists often are asked by patients who have recovered from COVID-19 why they need to be vaccinated since they already have natural antibodies to the virus. A new study provides a clear answer: It is a misconception that previous infection with SARS-CoV-2 guarantees a high level of antibodies or a strong response to the first mRNA vaccine dose. Find out why the authors strongly recommend those patients get two vaccine doses.
|
|
